Four top executives with West Chester, PA-based Synthes Inc. were indicted by the US Attorney for the Eastern District of Pennsylvania on charges that the company improperly engaged in off-label ...

Please provide your email address to receive an email when new articles are posted on . Synthes, Inc. announced that it has acquired The Anspach Effort, Inc., a global company in the high-speed ...

Last week, Fortune posted online an exposé titled "Bad to the bone: A medical horror story." The story centers around Norian XR, a calcium compound bone void filler linked to the deaths of at least ...

ZURICH (Reuters) - Swiss medical device maker Synthes posted a 24 percent rise in net profit to $348.8 million in the first-half of the year as high demand across all regions and product lines boosted ...

PHILADELPHIA -- A Swiss company with major operations in West Chester, Pa., illegally tested its bone cement on about 200 people, three of whom died, according to a 52-count indictment issued Tuesday, ...

Now that they've completed their stints in federal prison, four former Synthes executives have been essentially banished from the healthcare industry for their roles in the Norian bone cement scandal ...

Read more: UBS gaining support for compromise on Swiss capital rules Why studying Eastern European history is so political Read more: Why studying Eastern European history is so political How the UN ...

I write about the rapidly evolving artificial intelligence technology and its possible impacts on society. Originally from England, I spent some time at the BBC in London before moving to Switzerland ...

In the company’s most recent annual report, Wyss held 47 million shares of Synthes, or 40% of the company. Johnson & Johnson is buying Synthes for CHF 55.65 in cash and CHF 103.55 in J&J stock. (The ...

TRENTON, N.J. (AP) -- Healthcare giant Johnson & Johnson said Tuesday that it will complete its $19.7 billion purchase of Synthes on Thursday — a deal J&J hopes will give it a dominant position in the ...